Table 2.
Subgroup | Stroke | Ischemic stroke | Hemorrhagic stroke | Control group | |||
---|---|---|---|---|---|---|---|
TAFI (μg/mL) | P | TAFI (μg/mL) | P | TAFI (μg/mL) | P | TAFI (μg/mL) | |
Age | |||||||
≤60 | 31.16 (27.10–34.92) | 0.570 | 31.22 (27.14–34.88) | 0.529 | 30.63 (27.10–35.96) | 0.886 | 30.55 (26.06–35.18) |
>60 | 31.48 (27.33–35.25) | 0.016 | 31.73 (26.89–35.39) | 0.018 | 29.08 (28.19–32.97) | 0.321 | 28.00 (24.96–34.62) |
Gender | |||||||
Male | 30.48 (26.72–35.02) | 0.355 | 30.74 (26.70–35.02) | 0.394 | 30.05 (27.35–34.77) | 0.551 | 29.69 (25.03–34.89) |
Female | 32.32 (28.43–36.29) | 0.022 | 32.50 (28.48–36.81) | 0.017 | 31.36 (27.36–33.06) | 0.586 | 28.78 (25.57–35.03) |
P value came from the compare between each case group (stroke/ischemic stroke/hemorrhagic stroke) and the control group.